| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A hedonic price analysis for the Italian wine in the domestic market |
0 |
0 |
0 |
13 |
1 |
4 |
5 |
54 |
| A reply to “Who would benefit from average value‐based pricing?” |
0 |
0 |
1 |
4 |
2 |
2 |
3 |
22 |
| Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization |
0 |
0 |
0 |
1 |
1 |
2 |
4 |
10 |
| An Incremental Flypaper Model for English Local Government Expenditure Decisions |
0 |
0 |
0 |
0 |
1 |
3 |
3 |
32 |
| An Optimal Grants-in-Aid Allocation Rule in the Context of an Asymmetry-of-Information Model |
0 |
0 |
0 |
14 |
4 |
6 |
7 |
65 |
| Analysing Italian Local Authorities' Expenditure Behaviour: A Tentative Interpretation |
0 |
0 |
0 |
29 |
3 |
6 |
7 |
77 |
| Authors’ Reply to Garattini and Freemantle: “Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition” |
0 |
0 |
0 |
3 |
1 |
2 |
4 |
30 |
| Beyond price: the effects of non-financial barriers on access to drugs and health outcomes |
0 |
0 |
1 |
5 |
1 |
2 |
5 |
22 |
| Competition in the provision of hospital care: Are mixed markets a valid alternative? |
0 |
0 |
1 |
6 |
3 |
6 |
8 |
25 |
| Competition, value-based prices and incentives to research personalised drugs |
0 |
0 |
3 |
5 |
3 |
3 |
8 |
12 |
| Decentralized Budgeting Procedures for Public Expenditure |
0 |
0 |
1 |
25 |
1 |
2 |
6 |
90 |
| Delay and Public Expenditure Determination for Health Care |
0 |
0 |
0 |
10 |
2 |
2 |
3 |
81 |
| Determinants of the Growth of Transfers in the United Kingdom: A Causal Analysis |
0 |
0 |
0 |
4 |
2 |
2 |
2 |
24 |
| Does Government Expenditure Crowd Out Private Consumption in Italy? Evidence from a Microeconomic Model |
0 |
0 |
0 |
113 |
1 |
2 |
4 |
414 |
| Does the Flypaper Model Stick? A Test of the Relative Performance of the Flypaper and Conventional Models of Local Government Budgetary Behaviour |
0 |
0 |
0 |
0 |
2 |
5 |
6 |
316 |
| Dynamic Tax Evasion with Habit Formation in Consumption |
0 |
0 |
1 |
7 |
10 |
13 |
21 |
68 |
| Dynamic tax evasion with audits based on visible consumption |
0 |
0 |
1 |
11 |
8 |
9 |
16 |
90 |
| EXIT, CHOICE OR LOYALTY: PATIENT DRIVEN COMPETITION IN PRIMARY CARE |
0 |
0 |
0 |
28 |
4 |
4 |
5 |
144 |
| Emotional decision-makers and anomalous attitudes towards information |
0 |
0 |
0 |
33 |
6 |
6 |
9 |
162 |
| Emotions in physician agency |
0 |
0 |
0 |
37 |
3 |
4 |
12 |
130 |
| Even Some Lump-Sum Grants Can Stimulate More Than others |
0 |
0 |
0 |
8 |
4 |
8 |
9 |
63 |
| Fiscal Federalism in the presence of impure public goods |
0 |
0 |
1 |
6 |
1 |
2 |
5 |
35 |
| Fiscal Federalism, Patient Mobility and Soft Budget Constraint in Italy |
0 |
0 |
0 |
11 |
2 |
4 |
5 |
30 |
| Flypaper Effect and Sluggishness: Evidence from Regional Health Expenditure in Italy |
0 |
0 |
1 |
111 |
4 |
7 |
13 |
411 |
| From local to global public goods: How should externalities be represented? |
0 |
0 |
0 |
29 |
2 |
4 |
7 |
106 |
| Health Care Expenditure across OECD Countries: A Public Choice Approach |
0 |
0 |
0 |
0 |
1 |
4 |
6 |
165 |
| Health care expenditure decisions in the presence of devolution and equalisation grants |
0 |
0 |
1 |
10 |
2 |
2 |
5 |
63 |
| Hospital Health Care: Pricing and Quality Control in a Spatial Model with Asymmetry of Information |
0 |
0 |
0 |
201 |
4 |
5 |
7 |
1,259 |
| Hospitals’ strategic behaviours and patient mobility: Evidence from Italy |
0 |
0 |
0 |
3 |
1 |
1 |
4 |
33 |
| INVESTMENT IN HOSPITAL CARE TECHNOLOGY UNDER DIFFERENT PURCHASING RULES: A REAL OPTION APPROACH |
0 |
0 |
0 |
26 |
5 |
6 |
8 |
130 |
| Innovation, aging, and health care: Unraveling “silver” from “red” herrings? |
0 |
0 |
0 |
4 |
2 |
2 |
5 |
41 |
| Investment decisions in hospital technology when physicians are devoted workers |
0 |
0 |
0 |
52 |
2 |
3 |
4 |
337 |
| Is there a bias in patient choices for hospital care? Evidence from three Italian regional health systems |
0 |
0 |
2 |
3 |
4 |
5 |
9 |
13 |
| Is there scope for mixed markets in the provision of hospital care? |
0 |
0 |
0 |
14 |
3 |
4 |
8 |
53 |
| La crescita della spesa pubblica sanitaria in Italia: un modello incrementale misto |
0 |
0 |
0 |
3 |
1 |
2 |
2 |
27 |
| Lifestyle taxes in the presence of profit shifting |
0 |
0 |
0 |
4 |
4 |
7 |
11 |
24 |
| Local Authority Expenditure Decisions: A Maximum Likelihood Analysis of Budget Setting in the Face of Piecewise Linear Budget Constraints |
0 |
0 |
0 |
49 |
1 |
3 |
4 |
256 |
| Marketing and pricing strategies of online pharmacies |
0 |
0 |
0 |
72 |
2 |
6 |
6 |
318 |
| Merit goods provision and optimal tax evasion |
0 |
0 |
0 |
2 |
3 |
5 |
5 |
62 |
| NHS contracts: An agency approach |
0 |
0 |
1 |
4 |
1 |
1 |
4 |
9 |
| Not a good buy: Value for money of prescription drugs sold on the Internet |
0 |
0 |
1 |
6 |
4 |
5 |
10 |
49 |
| On the Intergovernmental Fiscal Game |
0 |
0 |
0 |
0 |
2 |
5 |
5 |
104 |
| Optimal Procurement Contracts under a Binding Budget Constraint |
0 |
0 |
0 |
43 |
3 |
4 |
5 |
200 |
| Optimal dynamic tax evasion |
0 |
0 |
0 |
61 |
1 |
5 |
10 |
210 |
| Optimal dynamic tax evasion: A portfolio approach |
0 |
0 |
0 |
27 |
0 |
2 |
6 |
110 |
| Optimal payment schemes for physicians |
0 |
0 |
0 |
2 |
3 |
5 |
10 |
40 |
| Optimal tax enforcement with productive public inputs |
0 |
0 |
1 |
3 |
5 |
8 |
11 |
19 |
| Optimizing the level of grant support for local government: An application of a behavioral model |
0 |
0 |
0 |
10 |
0 |
0 |
0 |
83 |
| Patient mobility and health care quality when regions and patients differ in income |
0 |
0 |
1 |
18 |
5 |
6 |
9 |
84 |
| Patient mobility in the context of austerity and an enlarged EU: The European Court of Justice's ruling in the Petru Case |
0 |
0 |
0 |
2 |
0 |
4 |
4 |
37 |
| Patient mobility, health care quality and welfare |
0 |
0 |
1 |
22 |
3 |
4 |
9 |
107 |
| Patient selection in a mixed oligopoly market for health care: the role of the soft budget constraint |
0 |
2 |
2 |
31 |
4 |
10 |
10 |
133 |
| Patients' migration across regions: the case of Italy |
0 |
1 |
3 |
113 |
3 |
9 |
14 |
385 |
| Pricing Personalised Drugs: Comparing Indication Value Based Prices with Performance Based Schemes |
0 |
0 |
0 |
0 |
3 |
4 |
5 |
9 |
| Pricing schemes for new drugs: A welfare analysis |
0 |
0 |
0 |
19 |
1 |
3 |
4 |
79 |
| Public expenditure spillovers: an explanation for heterogeneous tax reaction functions |
0 |
0 |
1 |
7 |
7 |
12 |
15 |
37 |
| REGULATION STRATEGIES FOR THE PROVISION OF PATERNALISTIC GOODS |
0 |
0 |
0 |
1 |
2 |
2 |
2 |
9 |
| Rationing in health care provision: a welfare approach |
0 |
0 |
0 |
2 |
1 |
2 |
3 |
36 |
| Razionalizzazione della spesa farmaceutica: farmaci costo efficaci in malattie cardiovascolari |
0 |
0 |
0 |
3 |
1 |
1 |
1 |
35 |
| Regulating internal markets for hospital care |
0 |
0 |
0 |
26 |
4 |
5 |
7 |
96 |
| Resilient managed competition during pandemics: lessons from the Italian experience during COVID-19 |
0 |
0 |
0 |
0 |
2 |
4 |
7 |
14 |
| Sectoral inflation under fragmentation of information |
0 |
0 |
5 |
5 |
3 |
12 |
22 |
22 |
| Sistemi di remunerazione per l'assistenza primaria in un contesto di asimmetria informativa |
0 |
0 |
0 |
2 |
0 |
0 |
1 |
24 |
| Soft budget constraints in health care: evidence from Italy |
0 |
0 |
1 |
9 |
2 |
3 |
5 |
55 |
| Spatial Competition Across Borders: The Role of Patients’ Mobility and Institutional Settings |
0 |
0 |
0 |
0 |
5 |
7 |
8 |
8 |
| Spatial Competition Models in Health Care Markets: A Review |
0 |
0 |
1 |
1 |
5 |
8 |
20 |
21 |
| Speeding up the clinical pathways by accessing emergency departments |
0 |
0 |
1 |
5 |
4 |
6 |
10 |
30 |
| Static and dynamic efficiency of irreversible health care investments under alternative payment rules |
0 |
0 |
0 |
21 |
4 |
5 |
6 |
153 |
| Strategic costs and preferences revelation in the allocation of resources for health care |
0 |
0 |
0 |
22 |
2 |
2 |
3 |
95 |
| Tax Evasion and the Cost of Public Sector Activities |
0 |
0 |
0 |
18 |
4 |
7 |
9 |
57 |
| Tax audits, fines and optimal tax evasion in a dynamic context |
0 |
0 |
1 |
55 |
2 |
3 |
7 |
155 |
| Tax avoidance and evasion in a dynamic setting |
0 |
0 |
1 |
5 |
6 |
11 |
29 |
62 |
| Tax evasion and debt in a dynamic general equilibrium model |
0 |
0 |
2 |
2 |
4 |
5 |
7 |
11 |
| Tax evasion and uncertainty in a dynamic context |
1 |
1 |
1 |
25 |
3 |
4 |
7 |
99 |
| The Dynamics of Pharmaceutical Regulation and R&D Investments |
0 |
0 |
1 |
10 |
4 |
5 |
6 |
69 |
| The Hedonic Price for Italian Red Wine: Do Chemical and Sensory Characteristics Matter? |
0 |
0 |
0 |
3 |
0 |
2 |
2 |
43 |
| The illness trap: The impact of disability benefits on willingness to receive HCV treatment |
0 |
0 |
0 |
1 |
5 |
7 |
12 |
16 |
| The provision of impure public goods in a non-competitive market |
0 |
0 |
0 |
67 |
1 |
1 |
2 |
251 |
| Two-part payments for the reimbursement of investments in health technologies |
0 |
0 |
0 |
13 |
4 |
7 |
11 |
63 |
| Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition |
0 |
1 |
2 |
10 |
1 |
4 |
6 |
56 |
| Waste-to-Energy in the EU: The Effects of Plant Ownership, Waste Mobility, and Decentralization on Environmental Outcomes and Welfare |
1 |
1 |
2 |
14 |
2 |
4 |
10 |
80 |
| Welfare properties of restrictions to health care based on cost effectiveness |
0 |
0 |
0 |
13 |
2 |
3 |
4 |
57 |
| When fear backfires: Emergency department accesses during the Covid-19 pandemic |
0 |
0 |
0 |
4 |
4 |
4 |
8 |
23 |
| Which valued‐based price when patients are heterogeneous? |
0 |
0 |
0 |
12 |
1 |
2 |
4 |
42 |
| With a little help from my (neighbouring) friends. ‘Border region patient mobility’ in the European Union: A policy analysis |
0 |
0 |
0 |
0 |
1 |
1 |
3 |
4 |
| Would less regional income distribution justify the present call for devolution? |
0 |
0 |
0 |
5 |
1 |
1 |
2 |
37 |
| Total Journal Articles |
2 |
6 |
43 |
1,678 |
232 |
380 |
616 |
8,712 |
LogEc is hosted by the
Örebro University School of Business.